Survey of Ophthalmology
Volume 45, Supplement 3 , Pages S250-S255, May 2001

New Horizons in Neuroprotection

  • Rita Naskar, PhD
  • ,
  • Evan B Dreyer, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint address: Evan Benjamin Dreyer, MD, PhD, Scheie Eye Institute, 51 North 39th Street, Philadelphia, PA 19104 USA

Scheie Eye Institute and Department of Ophthalmology, the University of Pennsylvania, Philadelphia, PA, USA

Abstract 

Glaucoma is a leading cause of blindness worldwide and the second leading cause of irreversible blindness in the USA. The most common form of glaucoma, primary open angle glaucoma, is characterized by a chronically elevated intraocular pressure in the absence of any demonstrable structural abnormalities in the eye. The pathologic hallmark of glaucomatous optic neuropathy is the selective death of retinal ganglion cells associated with structural changes in the optic nerve head. Recent discoveries suggest a role for nitric oxide, glutamate, apoptosis, and others, in the pathophysiology of this neuropathy. These newer discoveries are addressed in this article.

Keywords:  apoptosis, caspase, glaucoma, glutamate, nitric oxide, retinal, ganglion cells

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0039-6257(01)00198-9

Survey of Ophthalmology
Volume 45, Supplement 3 , Pages S250-S255, May 2001